hide
Free keywords:
Breast Neoplasms/*genetics/metabolism/pathology
Cell Line, Tumor
Coculture Techniques
*Epistasis, Genetic
Female
Gene Regulatory Networks
*Genes, Essential
Genome, Human
Humans
Mutation
Neoplasm Proteins/*genetics/metabolism
Ovarian Neoplasms/*genetics/metabolism/pathology
PTEN Phosphohydrolase/deficiency/*genetics
Pancreatic Neoplasms/*genetics/metabolism/pathology
RNA, Small Interfering/genetics/metabolism
Abstract:
Improved efforts are necessary to define the functional product of cancer mutations currently being revealed through large-scale sequencing efforts. Using genome-scale pooled shRNA screening technology, we mapped negative genetic interactions across a set of isogenic cancer cell lines and confirmed hundreds of these interactions in orthogonal co-culture competition assays to generate a high-confidence genetic interaction network of differentially essential or differential essentiality (DiE) genes. The network uncovered examples of conserved genetic interactions, densely connected functional modules derived from comparative genomics with model systems data, functions for uncharacterized genes in the human genome and targetable vulnerabilities. Finally, we demonstrate a general applicability of DiE gene signatures in determining genetic dependencies of other non-isogenic cancer cell lines. For example, the PTEN(-/-) DiE genes reveal a signature that can preferentially classify PTEN-dependent genotypes across a series of non-isogenic cell lines derived from the breast, pancreas and ovarian cancers. Our reference network suggests that many cancer vulnerabilities remain to be discovered through systematic derivation of a network of differentially essential genes in an isogenic cancer cell model.
